Table 1 Demographic and clinical characteristics
Characteristic | Total patients n = 165 |
|---|---|
Sex (n, %) | |
Male | 103 (62.4) |
Female | 62 (37.6) |
Age, years (IQR) | 46 (32.5–61) |
Region of origin (n, %) | |
Canadian born | 44 (26.7) |
Foreign born | |
TB incidence >30 per 100,000 | 115 (69.7) |
TB incidence of ≤30 per 100,000 | 5 (3.0) |
Unknown country of birth | 1 (0.6) |
Year of diagnosis | |
2002–2006 | 37 (22.4) |
2007–2010 | 56 (33.9) |
2011–2014 | 72 (43.6) |
Co-morbidities (n, %) | |
Diabetes mellitus | 19 (11.5) |
Immune suppressive medication | 13 (7.9) |
Malignancy | 7 (4.2) |
HIV positive | 6 (3.6) |
Chronic kidney disease | 2 (1.2) |
Prior history of TB treatment | |
No prior TB treatment | 127 (77.0) |
Prior TB treatment | 24 (14.5) |
Prior TB treatment unknown | 14 (8.5) |
Disease site | |
Pulmonary | 106 (64.2) |
Extra-pulmonary | 42 (25.5) |
Pulmonary and extra-pulmonary | 17 (10.3) |
Extent of pulmonary diseasea | |
Baseline positive AFB smear | 73 (59.3) |
Cavitary lesions in chest radiography | 50 (40.7) |
Isoniazid resistance (n, %) | |
INH, both high and low level resistance | 84 (50.9) |
INH, only low level resistance | 81 (49.1) |